` ECS (ECS Botanics Holdings Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

ECS
vs
S
S&P/ASX 300

Over the past 12 months, ECS has underperformed S&P/ASX 300, delivering a return of -64% compared to the S&P/ASX 300's +5% growth.

Stocks Performance
ECS vs S&P/ASX 300

Loading
ECS
S&P/ASX 300
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ECS vs S&P/ASX 300

Loading
ECS
S&P/ASX 300
Difference
www.alphaspread.com

Performance By Year
ECS vs S&P/ASX 300

Loading
ECS
S&P/ASX 300
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
ECS Botanics Holdings Ltd vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

ECS Botanics Holdings Ltd
Glance View

Market Cap
8m AUD
Industry
Pharmaceuticals

ECS Botanics Holdings Ltd. manufactures, supplies and retails cannabis products. The company is headquartered in Perth, Western Australia. The firm operates in two segments: ECS Botanics Pty Ltd is engaged in the sale of food and wellness products, and Murray Meds Pty Ltd and Flowerday Farms Pty Ltd are engaged in the sale of medicinal cannabis plant-related products. The firm offers Extra Virgin Tasmanian Hemp Seed Oil, Australian Hemp Seed Oil Capsules, Australian Hemp Seed Oil Capsules with Turmeric, Australian Hemp Hearts (Dehulled Seeds), Australian Hemp Protein, Natural Calm Terpene Blend, Natural Relief Terpene Blend, Natural Sleep Terpene Blend, Mexican Spiced Bean Soup and Indian Masala Lentil Soup. The firm owns farms and medicinal cannabis facilities in Tasmania and Victoria for the cultivation, processing and manufacturing of medicinal cannabis.

ECS Intrinsic Value
0.035 AUD
Undervaluation 86%
Intrinsic Value
Price
Back to Top